Cargando…

High Mutational Heterogeneity, and New Mutations in the Human Coagulation Factor V Gene. Future Perspectives for Factor V Deficiency Using Recombinant and Advanced Therapies

Factor V is an essential clotting factor that plays a key role in the blood coagulation cascade on account of its procoagulant and anticoagulant activity. Eighty percent of circulating factor V is produced in the liver and the remaining 20% originates in the α-granules of platelets. In humans, the f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernal, Sara, Pelaez, Irene, Alias, Laura, Baena, Manel, De Pablo-Moreno, Juan A., Serrano, Luis J., Camero, M. Dolores, Tizzano, Eduardo F., Berrueco, Ruben, Liras, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465496/ https://www.ncbi.nlm.nih.gov/pubmed/34575869 http://dx.doi.org/10.3390/ijms22189705

Ejemplares similares

The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V
por: Pablo-Moreno, Juan A. De, et al.
Publicado: (2022)

Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models
por: De Pablo-Moreno, Juan A., et al.
Publicado: (2022)

Development and Characterization of a Factor V-Deficient CRISPR Cell Model for the Correction of Mutations
por: Serrano, Luis Javier, et al.
Publicado: (2022)

The Association of Coagulation Factor V (Leiden) and Factor II (Prothrombin) Mutations With Stroke
por: Pirhoushiaran, Maryam, et al.
Publicado: (2014)

Pharmacogenetic typing for oral anti-coagulant response among factor V Leiden mutation carriers
por: Nahar, Risha, et al.
Publicado: (2012)

Novel mutation in coagulation factor VII (Carmel mutation): Identification and characterization
por: Cassel, Aliza, et al.
Publicado: (2021)

Novel single nucleotide mutations in exon-10 of human coagulation Factor V gene in patients with pulmonary thromboembolism
por: Kasala, Latheef, et al.
Publicado: (2020)

Prevalence of common hereditary risk factors for thrombophilia in Somalia and identification of a novel Gln544Arg mutation in coagulation factor V
por: Abdi, Abshir Ali, et al.
Publicado: (2017)

Dabrafenib and Trametinib prolong coagulation through the inhibition of tissue factor in BRAF(v600e) mutated melanoma cells in vitro
por: Scatena, Cristian, et al.
Publicado: (2019)

Congenital coagulation factor V deficiency with intracranial hemorrhage
por: Yang, Jingjing, et al.
Publicado: (2022)

Cryo-EM structure of coagulation factor V short
por: Mohammed, Bassem M., et al.
Publicado: (2023)

Development and Characterization of Recombinant Ovine Coagulation Factor VIII
por: Zakas, Philip M., et al.
Publicado: (2012)

Bacterial Production of Recombinant Coagulation Factor VIII Domains
por: Bashar, Saima, et al.
Publicado: (2023)

The Magic of Proteases: From a Procoagulant and Anticoagulant Factor V to an Equitable Treatment of Its Inherited Deficiency
por: De Pablo-Moreno, Juan A., et al.
Publicado: (2023)

Novel factor VII gene mutations in six families with hereditary coagulation factor VII deficiency
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

Understanding the Impact of Aberrant Splicing in Coagulation Factor V Deficiency
por: Paraboschi, Elvezia Maria, et al.
Publicado: (2019)

SV-IV Peptide1–16 reduces coagulant power in normal Factor V and Factor V Leiden
por: Di Micco, Biagio, et al.
Publicado: (2007)

Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant
por: Hamada, Mostafa, et al.
Publicado: (2021)

Positive Selection during the Evolution of the Blood Coagulation Factors in the Context of Their Disease-Causing Mutations
por: Rallapalli, Pavithra M., et al.
Publicado: (2014)

Mutations in Coagulation Factor VIII Are Associated with More Favorable Outcome in Patients with Cutaneous Melanoma
por: Ping, Zheng, et al.
Publicado: (2017)

PB2660: HEREDITARY COAGULATION FACTOR FVII DEFICIENCY CAUSED BY COMPOUND HETEROZYGOUS MUTATIONS
por: Zhou, Rongfu, et al.
Publicado: (2023)

Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
por: Kim, T. W., et al.
Publicado: (1998)

Generation of coagulation factor V activity by cultured rabbit alveolar macrophages
Publicado: (1984)

Development of a microplate coagulation assay for Factor V in human plasma
por: Tilley, Derek, et al.
Publicado: (2011)

A Case of Coagulation Factor V Deficiency Complicated with Intracranial Hemorrhage
por: Yoon, Suk-Gu, et al.
Publicado: (1997)

Myotonic Dystrophy-1 Complicated by Factor-V (Leiden) Mutation
por: Finsterer, Josef, et al.
Publicado: (2015)

Combination of factor V Leiden and MTHFR mutations in myocardial infarction
por: Fekih-Mrissa, Najiba, et al.
Publicado: (2013)

Recombinant proteins in therapeutics: haemophilia treatment as an example
por: Liras, Antonio
Publicado: (2008)

Human coagulation factor VIII domain-specific recombinant polypeptide expression
por: Choi, Su Jin, et al.
Publicado: (2015)

Engineering CRISPR/Cas9 for Multiplexed Recombinant Coagulation Factor Production
por: Feser, Colby J., et al.
Publicado: (2022)

Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2
por: Patiño-Galindo, Juan Ángel, et al.
Publicado: (2021)

Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2
por: Patiño-Galindo, Juan Ángel, et al.
Publicado: (2021)

Multiplex testing for Factor II and Factor V mutations in thrombophilia: technical verification and clinical validation of the cobas® Factor II and Factor V test
por: Longshore, John W., et al.
Publicado: (2018)

Characterization of a Missense Mutation in the Catalytic Domain and a Splicing Mutation of Coagulation Factor X Compound Heterozygous in a Chinese Pedigree
por: Feng, Yuanzheng, et al.
Publicado: (2021)

Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation
por: Santamaria, Salvatore, et al.
Publicado: (2017)

Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor
por: Eslamifar, Zahra, et al.
Publicado: (2020)

Acquired Coagulation Factor V Inhibitor That Was Successfully Treated with Oral Corticosteroid Therapy
por: Yokota, Yoshihiro, et al.
Publicado: (2021)

Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19
por: Wang, Jun, et al.
Publicado: (2022)

Clinical Phenotype and Genetic Analysis of Twins With Congenital Coagulation Factor V Deficiency
por: Wei, Yanhui, et al.
Publicado: (2022)

Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential
por: Nakajima, Yuto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ctd7a8h9km725a2qi1k6airafu